Antibody Protein ELISA Kit from MyBioSource header Telephone 1.858.633.0165          
1.855.MyBioSource
Fax 1.858.633.0166    Email sales@mybiosource.com 
tel/fax
menu1 Home Products Ordering Company Help menu7
bottom
   MyBioSource  rightarrow Blog  rightarrow MYOF sirna  rightarrow LOG IN  rightarrow MY ACCOUNT  rightarrow CART CONTENTS  rightarrow CHECKOUT 
horiz bar
MyBioSource Blogs moreseparator
separator
 • GAS2L2 sirna blog
 • FN1 peptide blog
 • anti-MADD antibody blog
 • RNF4 recombinant protein blog
 • g-[6-Aminohexyl]-GTP nucleotide blog
 • NOL4 sirna blog
 • OSCP1 sirna blog
 • KRTAP6-5 shrna blog
 • hsa-miR-6832-5p mirna blog
 • anti-APAF1 antibody blog
 • CCK-33 peptide antisera blog
 • PTX3 elisa kit blog
 • anti-CD54 antibody blog
 • ACOT9 blocking peptide blog
 • CHST12 sirna blog
 • anti-Pzp antibody blog
 • TRIM40 sirna blog
 • anti-Quinidine antibody blog
 • ANGPTL4 sirna blog
 • CIAPIN1 shrna blog
separator
Blog Categories separator
separator
 • Assay Kit Blogs
 • Biochemical Blogs
 • cDNA Clone Blogs
 • Monoclonal Antibody Blogs
 • Polyclonal Antibody Blogs
 • Rec/Purified Protein Blogs
 • Popular Product Blogs
separator
Our Best Sellers moreseparator
separator
 • Kir6.2 (KCNJ11) Antibody
 • PRDX6 Antibody
 • NACA Antibody
 • carboxylesterase 1 (monocyte-macrophage serine esterase 1) ... ELISA Kit
 • solute carrier family 46 (folate transporter) , member 1 (SL... ELISA Kit
 • PDE5A Antibody
 • STAT3 Antibody
 • EIF4E3 Antibody
 • cysteinyl-tRNA synthetase (CARS) ELISA Kit
 • CK1 Antibody
 • PPP2CA Antibody
 • SPRR2A Antibody
 • ATF7 Antibody
 • UQCRQ Antibody
 downarrow more ...
separator

MYOF sirna product blog

separator
Posted on 2015-12-02 05:42:09 by mybiosource_staff
Share it on ...     
separator
separator
Tags: MYOF; siRNA; MYOF sirna;
separator
The MYOF myof (Catalog #MBS8219327) is a siRNA produced from Synthetic and is intended for research purposes only. The product is available for immediate purchase. The MYOF siRNA (Human) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s MYOF can be used in a range of immunoassay formats including, but not limited to, RNA Interference (RNAi). Researchers should empirically determine the suitability of the MYOF myof for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.

The MYOF myof product has the following accession number(s) (GI #7305053) (NCBI Accession #NP_038479.1) (Uniprot Accession #Q9NZM1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.

To buy or view more detailed product information and pricing, please click on the technical datasheet page below:


siRNA to inhibit MYOF expression using RNA interference.

MYOF myof

Quality Control: Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
Directions for Use: We recommends transfection with 100 nM siRNA 48 to 72 hours prior to cell lysis. Before resuspending, briefly centrifuge the tube to ensure the lyophilized siRNA is at the bottom of the tube. Resuspend the siRNA oligos to an appropriate concentration with DEPC water. For each vial, suitable for 250 transfections in 24 well plate (20 pmol for each well).
Components: We offer pre-designed sets of 3 different target-specific siRNA oligo duplexes of human MYOF gene. Each vial contains 5 nmol of lyophilized siRNA. The duplexes can be transfected individually or pooled together to achieve knockdown of the target gene, which is most commonly assessed by qPCR or western blot. Our siRNA oligos are also chemically modified (2\'-OMe) at no extra charge for increased stability and enhanced knockdown in vitro and in vivo. Adenocarcinoma, Breast Neoplasms, Cardiovascular Diseases, Disease Models, Animal, Fibrosis, Hypertrophy, Kidney Diseases, Lung Neoplasms, Neoplasm Metastasis, Nervous System Diseases are some of the diseases may be linked to MYOF siRNA (Human). Blood, Bone, Connective Tissue, Embryonic Tissue, Heart, Kidney, Lung, Muscle, Placenta, Vascular tissues are correlated with this protein. MYOF also interacts with the following gene(s): CBL, EHD2, TJP1.
horiz bar
 SSL   Follow us on Facebook Follow us onTwitter Follow us on Google Plus Connect us on LinkedIn Subscribe to our RSS Feed for latest products and special promotions